Arginine Deprivation as a Targeted Therapy for Cancer

E-ISSN： 1873-4286|14|11|1049-1057

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.14, Iss.11, 2008-04, pp. : 1049-1057

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Androgen deprivation therapy for prostate cancer

By Singer Eric A Golijanin Dragan J Miyamoto Hiroshi Messing Edward M

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 2, 2008-02 ,pp. : 211-228

Informa Healthcare

Access to resources Recommend Favorite

Targeted therapy of hepatocellular cancer

By Wysocki Piotr Jan

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 2, 2010-02 ,pp. : 265-274

Informa Healthcare

Access to resources Recommend Favorite

Endoglin-Targeted Cancer Therapy

Current Drug Delivery, Vol. 8, Iss. 1, 2011-01 ,pp. : 135-143

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted Therapy of Breast Cancer

Current Pharmaceutical Design, Vol. 13, Iss. 5, 2007-02 ,pp. : 497-517

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted therapy for epithelial ovarian cancer

By Sharma Sameer Odunsi Kunle

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 3, 2005-06 ,pp. : 501-513

Informa Healthcare

Access to resources Recommend Favorite